T1	Participants 142 194	patients with the acquired immunodeficiency syndrome
T2	Participants 552 571	10 adults with AIDS
T3	Participants 572 721	who had recently recovered from an initial episode of PCP and had no treatment-limiting toxic effects of trimethoprim-sulfamethoxazole or pentamidine
T4	Participants 2124 2171	patients with AIDS who are receiving zidovudine
